AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Ligands

Showing 321 to 330 of 600 articles

Clear Filters

Expanding the drug discovery space with predicted metabolite-target interactions.

Communications biology
Metabolites produced in the human gut are known modulators of host immunity. However, large-scale identification of metabolite-host receptor interactions remains a daunting challenge. Here, we employed computational approaches to identify 983 potenti...

Trends in application of advancing computational approaches in GPCR ligand discovery.

Experimental biology and medicine (Maywood, N.J.)
G protein-coupled receptors (GPCRs) comprise the most important superfamily of protein targets in current ligand discovery and drug development. GPCRs are integral membrane proteins that play key roles in various cellular signaling processes. Therefo...

Androgen Receptor Binding Category Prediction with Deep Neural Networks and Structure-, Ligand-, and Statistically Based Features.

Molecules (Basel, Switzerland)
Substances that can modify the androgen receptor pathway in humans and animals are entering the environment and food chain with the proven ability to disrupt hormonal systems and leading to toxicity and adverse effects on reproduction, brain developm...

Coloring Molecules with Explainable Artificial Intelligence for Preclinical Relevance Assessment.

Journal of chemical information and modeling
Graph neural networks are able to solve certain drug discovery tasks such as molecular property prediction and molecule generation. However, these models are considered "black-box" and "hard-to-debug". This study aimed to improve modeling transparen...

Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization.

Archivos de bronconeumologia
BACKGROUND: Differentiating between nontuberculous mycobacterial lung disease (NTM-LD) and pulmonary NTM colonization (NTM-Col) is difficult. Compared with healthy controls, patients with NTM-LD generally present immune tolerance along with increased...

Machine learning classifiers aid virtual screening for efficient design of mini-protein therapeutics.

Bioorganic & medicinal chemistry letters
De novo design of mini-proteins (4-12 kDa) has recently been shown to produce new candidates for protein therapeutics. They are temperature stable molecules that bind to the drug target with high affinity for inhibiting its interactions. The developm...

OctSurf: Efficient hierarchical voxel-based molecular surface representation for protein-ligand affinity prediction.

Journal of molecular graphics & modelling
Voxel-based 3D convolutional neural networks (CNNs) have been applied to predict protein-ligand binding affinity. However, the memory usage and computation cost of these voxel-based approaches increase cubically with respect to spatial resolution and...

In silico design of novel aptamers utilizing a hybrid method of machine learning and genetic algorithm.

Molecular diversity
Aptamers can be regarded as efficient substitutes for monoclonal antibodies in many diagnostic and therapeutic applications. Due to the tedious and prohibitive nature of SELEX (systematic evolution of ligands by exponential enrichment), the in silico...

New machine learning and physics-based scoring functions for drug discovery.

Scientific reports
Scoring functions are essential for modern in silico drug discovery. However, the accurate prediction of binding affinity by scoring functions remains a challenging task. The performance of scoring functions is very heterogeneous across different tar...

SSnet: A Deep Learning Approach for Protein-Ligand Interaction Prediction.

International journal of molecular sciences
Computational prediction of Protein-Ligand Interaction (PLI) is an important step in the modern drug discovery pipeline as it mitigates the cost, time, and resources required to screen novel therapeutics. Deep Neural Networks (DNN) have recently show...